Aperio Announces Strategic Collaboration with Dell

AperioAperio, the leading provider of digital pathology systems, announced a strategic collaboration with Dell to create the world's first scalable, secure medical cloud network for Pathology.

Through its secure cloud-based Unified Clinical Archive solution, Dell manages nearly 5 billion medical images and studies for healthcare organizations. And now, Dell will host the existing suite of Aperio's industry-leading solutions for digital pathology. Fortified by Dell's standards-based technology and storage capabilities, Aperio's ePathology Network™ solution will provide secure, compliant, worldwide access to pathology consultations via the cloud.

"Our goal is to address the regional and global imbalances of pathology expertise available for patient care by enabling access to pathologists for all types of consultations, regardless of location. With Dell's cloud-based archiving platform, we can make our ePathology Solutions™ more widely available." said David Schlotterbeck, CEO of Aperio.

"This state-of-the-art ePathology Network technology from Aperio will revolutionize the practice of secondary consultations," states Dr. Jonathan Epstein, Director of Surgical Pathology at Johns Hopkins. "We fully expect that the time to return an opinion on these cases will be significantly reduced - from multiple days to as a few as a couple of hours in critical cases. This will have a significant positive impact on patient care."

Dell and Aperio are also collaborating to develop the world's leading repository of characterized digital slide images and cases, which will include the Juan Rosai Collection of Surgical Pathology Seminars. This furthers another mission of Aperio to make quality educational and reference materials more readily available to all pathologists around the world. The eSlide Repository™ will be a fulcrum for the healthcare and life sciences industries' focus on personalized medicine and enhanced precision and predictability.

"Dell is excited to work with Aperio to facilitate the archiving and sharing of whole slide pathology images via the cloud," said James Coffin, Ph.D., vice president and general manager of Dell Healthcare and Life Sciences. "This is a prime example of how on-premise and cloud-based solutions with application-neutral data management capabilities can break down traditional information silos and allow healthcare organizations to securely manage, store and share data to advance patient care."

About Aperio
For over a decade, Aperio has advanced the technology that enables glass slides to be digitized and securely shared with others. Aperio products are transforming the practice of pathology in hospitals, reference labs and pharmaceutical and research institutions around the world. From the moment glass slides are elevated to eSlides, Aperio ePathology Solutions equip pathologists with the power to evaluate, engage and excel like never before. The NETWORK enables remote, simultaneous, real-time viewing and easy distribution for consults and collaboration. PRECISION tools empower pathologists with advanced analytic capabilities. An interoperable, scalable and secure web-based software platform facilitates integration with existing systems. With Aperio ePathology Solutions, organizations can optimize their pathology operations for transparency, consistency and efficiency to support patient care, personalized medicine and research. For clearance updates, specific product indications, and more information please visit www.aperio.com.

Most Popular Now

Artificial Intelligence: Unexpected Resu…

Artificial intelligence (AI) is on the rise. Until now, AI applications generally have "black box" character: How AI arrives at its results remains hidden. Prof. Dr. Jürgen Bajorath, a cheminformatics...

Printed Robots with Bones, Ligaments, an…

3D printing is advancing rapidly, and the range of materials that can be used has expanded considerably. While the technology was previously limited to fast-curing plastics, it has now been...

AI identifies Non-Smokers at High Risk f…

Using a routine chest X-ray image, an artificial intelligence (AI) tool can identify non-smokers who are at high risk for lung cancer, according to a study being presented next week...

Orchestrating the New World of AI in Hea…

Orion Health's UK and Ireland Customer Conference 2023 focused on the future potential and immediate, practical application of AI to healthcare - and gave delegates a first look at the...

Study Reveals Bias in AI Tools when Diag…

Machine learning algorithms designed to diagnose a common infection that affects women showed a diagnostic bias among ethnic groups, University of Florida researchers found. While artificial intelligence (AI) tools offer...

Researchers Take New AI Approach to Anal…

Researchers at Karolinska Institutet and SciLifeLab in Sweden have combined artificial intelligence (AI) techniques used in satellite imaging and community ecology to interpret large amounts of data from tumour tissue...

Medical AI Tool from UF, NVIDIA gets Hum…

A new artificial intelligence (AI) computer program created by researchers at the University of Florida and NVIDIA can generate doctors' notes so well that two physicians couldn't tell the difference...

Commission Opens Calls to Invest €42 Mil…

Today, the European Commission opened a new set of calls for proposals under the 2023-2024 Work Programmes of the Digital Europe Programme with a focus on advanced digital skills. The calls...

Bayer Championing Advancements in Radiol…

Bayer continues to advance its comprehensive Radiology portfolio with progress in the development pipeline of its investigational contrast agent as well as new innovations in the area of Artificial Intelligence...

MEDICA and COMPAMED: Medical Technology …

13 - 16 November 2023, Düsseldorf, Germany. After four days of business, MEDICA and COMPAMED in Düsseldorf delivered impressive confirmation that they are excellent platforms for the worldwide medical technology business...

AI Predicts Developmental Paths in Prema…

Researchers at UMC Utrecht have developed an AI model to predict long-term outcome in extremely premature babies early in life. The model can identify which infants might face intellectual disability...

AI Paves Way for New Medicines

A team of researchers from LMU, ETH Zurich, and Roche Pharma Research and Early Development (pRED) Basel has used artificial intelligence (AI) to develop an innovative method that predicts the...